Resonance Specialties Limited (BOM:524218)
164.10
-5.20 (-3.07%)
At close: Aug 21, 2026
Resonance Specialties Revenue
Resonance Specialties had revenue of 325.84M INR in the quarter ending June 30, 2026, with 53.16% growth. This brings the company's revenue in the last twelve months to 1.02B, up 24.19% year-over-year. In the fiscal year ending March 31, 2026, Resonance Specialties had annual revenue of 902.48M with 15.99% growth.
Revenue (ttm)
1.02B
Revenue Growth
+24.19%
P/S Ratio
1.87
Revenue / Employee
13.72M
Employees
74
Market Cap
1.89B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 902.48M | 124.41M | 15.99% |
| Mar 31, 2025 | 778.07M | 225.06M | 40.70% |
| Mar 31, 2024 | 553.01M | -35.14M | -5.97% |
| Mar 31, 2023 | 588.15M | -169.43M | -22.36% |
| Mar 31, 2022 | 757.57M | 48.62M | 6.86% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Anlon Healthcare | 2.26B |
| Influx Healthtech | 1.47B |
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.12B |
| Panchsheel Organics | 1.08B |
| Shree Ganesh Remedies | 989.78M |
| Tyche Industries | 500.33M |